Clinical Significance of Early Application of Belimumab in the Treatment of Systemic Lupus Erythematosus in Children

Niu Xiaoling; Hao Sheng; Kang Yulin; Kuang Xinyu; Feng Dan; Huang Wenyan

doi:10.13407/j.cnki.jpp.1672-108X.2023.08.012

您当前的位置：

首页 >

文章列表页 >

Clinical Significance of Early Application of Belimumab in the Treatment of Systemic Lupus Erythematosus in Children

更新时间：2023-08-23

- Clinical Significance of Early Application of Belimumab in the Treatment of Systemic Lupus Erythematosus in Children
- Vol. 29, Issue 8, Pages: 42-45(2023)
- 作者机构：
  
  上海交通大学医学院附属儿童医院,上海市儿童医院,上海,200062
- 作者简介：
- 基金信息：
- DOI：10.13407/j.cnki.jpp.1672-108X.2023.08.012
  CLC：
- Published：2023，
  
  Published Online：10 August 2023，
扫描看全文
Niu Xiaoling, Hao Sheng, Kang Yulin, et al. Clinical Significance of Early Application of Belimumab in the Treatment of Systemic Lupus Erythematosus in Children. [J]. 29(8):42-45(2023)
DOI：

Niu Xiaoling, Hao Sheng, Kang Yulin, et al. Clinical Significance of Early Application of Belimumab in the Treatment of Systemic Lupus Erythematosus in Children. [J]. 29(8):42-45(2023) DOI： 10.13407/j.cnki.jpp.1672-108X.2023.08.012.

摘要

目的:探讨早期应用贝利尤单抗(BLM)治疗儿童系统性红斑狼疮(SLE)的价值。方法:选取我院肾脏风湿免疫科 2020-2021 年住院确诊为 SLE 的患儿 23 例

分为三组:对照组(初诊未用 BLM)7 例、初发组(初诊即用 BLM)7 例、复发组(复发才用BLM)9 例

分析三组患儿使用 BLM 前后相关炎症指标、系统性红斑狼疮疾病活动度(SLEDAI)评分、激素用量等变化

比较三组患儿临床疗效。结果:儿童 SLE 使用 BLM 后激素用量、SLEDAI 评分、血沉均降低(P 均<0. 01)

且初发组临床缓解时间、激素用量、SLEDAI 评分均小于对照组(P 均<0. 05);复发组临床缓解时间长于初发组(P<0. 05);临床缓解时间与病程呈正相关(r =0. 606

P<0. 05)。结论:BLM 治疗儿童 SLE 安全有效

可减少激素用量

降低疾病活动度

且早期应用更易缓解疾病。

Abstract

Objective: To probe into the value of early application of belimumab ( BLM) in the treatment of systemic lupus erythematosus (SLE) in children. Methods: A total of 23 children diagnosed with SLE admitted into the renal rheumatology department in our hospital from 2020 to 2021 were divided into three groups: control group (7 cases without BLM at initial diagnosis)

initial onset group (7 cases with BLM at initial diagnosis)

and recurrence group ( 9 cases with BLM only at recurrence). Changes of related inflammatory indicators

systemic lupus erythematosus disease activity index (SLEDAI) score and hormone dosage before and after BLM treatment in three groups were analyzed. Clinical efficacy of three groups were compared. Results: Hormone dosage

SLEDAI score and erythrocyte sedimentation rate decreased after BLM treatment in children with SLE (P<0. 01)

and clinical remission time

hormone dosage and SLEDAI score in the initial onset group were lower than those in the control group ( P< 0. 05). The duration of clinical remission in relapse group was longer than that in initial onset group ( P < 0. 05). The duration of clinical remission was positively correlated with the course of disease (r = 0. 606

P<0. 05). Conclusion: BLM is safe and effective in the treatment of SLE in children

which can reduce hormone dosage and disease activity

and early application is more likely to achieve disease remission.

关键词

贝利尤单抗儿童系统性红斑狼疮疗效

Keywords

belimumabchildrensystemic lupus erythematosusefficacy

references

查看原文

Views

126

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Comparison of Efficacy and Safety of Dexamethasone Versus Methylprednisolone in the Treatment ofChildren with Refractory Mycoplasma Pneumoniae Pneumonia

Analysis of 36 Cases of Drug Poisoning in Children in a Grade III, Level A General Hospital andConsideration on Pharmaceutical Care

Application of Dexmedetomidine Combined with Hydromorphone Nasal Drip in Sedation of Mother-InfantSeparation before Adenoidectomy

Sirolimus in the Treatment of 5 Cases of Blue Rubber Bleb Nevus Syndrome in Children and Literature Review

Systematic Review on Efficacy and Safety of Zoledronic Acid in the Treatment of Bone Metabolic Disordersin Children

Related Author

He Yang

Gao Rongrong

Song Shiqing

Lyu Xiaoqian

Ma Zhongzheng

Yin Zhanru

Wang Peng

Xu Ying

Related Institution

Hengshui People’ sHospital, Hebei Hengshui

Shenzhou People’s Hospital, Hebei Shenzhou

The Second People’ s Hospital of Anhui Wuhu, Anhui Wuhu

Jiangsu Taizhou People’s Hospital, Jiangsu Taizhou

Children’s Hospital Affiliated to Zhengzhou University,Henan Children’s Hospital, Zhengzhou Children’s Hospital, Zhengzhou Key Laboratory of Children’s Digestive Diseases

⁰